<DOC>
	<DOCNO>NCT02058199</DOCNO>
	<brief_summary>The investigator attempt compare anticoagulant ( blood thin ) effect recently FDA approve medication , Rivaroxaban , people undergo gastric bypass surgery people surgery . It think gastric bypass may alter absorption medication , previously study . The investigator study anticoagulant effect rivaroxaban healthy volunteer one four group 1 . Non obese people gastric bypass . 2 . Obese people gastric bypass 3 . People gastric bypass 4 . People plan undergo gastric bypass surgery near future willing studied bypass . The study involve take single low dose rivaroxaban multiple blood sample take next 24 hour effect rivaroxaban blood clotting measure use prothrombin time anti-factor Xa assay . The effect rivaroxaban compare different group .</brief_summary>
	<brief_title>Rivaroxaban Effects Subjects Who Have Undergone Gastric Bypass Surgery</brief_title>
	<detailed_description />
	<mesh_term>Rivaroxaban</mesh_term>
	<criteria>Healthy volunteer one four group 1 . Normal weight prior gastric bypass surgery , 2 . Obese prior gastric bypass surgery , 3 . Subjects prior roux en Y gastric bypass surgery , 4 . Obese plan undergo roux en Y gastric bypass Active renal liver disease , bleed diathesis , concurrent treatment anticoagulant aspirin , indication aspirin anticoagulant treatment , gastrointestinal bleeding , uncontrolled hypertension , active malignancy , anemia , thrombocytopenia , pregnant , allergy rivaroxaban , coagulopathy medical condition would increase risk subject</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>gastric bypass</keyword>
	<keyword>rivaroxaban</keyword>
	<keyword>pharmacodynamics</keyword>
</DOC>